ReShape Lifesciences (RSLS) announced that it has signed an agreement with Haifa, Israel-based Motion Informatics to exclusively import and distribute their next-generation neuromuscular rehabilitation devices in the U.S. The flagship product, the Stimel-03, was showcased at the American Occupational Therapy Association 2025 Annual Conference and Expo, held April 3-5 in Philadelphia, Pennsylvania.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RSLS:
- ReShape Lifesciences Delays Yearly Report Filing
- ReShape Lifesciences Faces Board Resignation Challenge
- ReShape receives notice of allowance for patent related to Neuromodulation
- ReShape Lifesciences signs distribution agreement with Liaison Medical
- ReShape Lifesciences Announces Securities Purchase Agreement